Suppression of nNOS expression in rat enteric neurones by the receptor for advanced glycation end-products

Neurogastroenterology and Motility

Volumn 18, Issue 5, 2006, Pages 392-400

  Korenaga, K ^a   Micci, M A ^a   Taglialatela, G ^a   Pasricha, P J ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Advanced glycation end products; Diabetic complications; Enteric nervous system; Neuronal nitric oxide synthase; Nitric oxide

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BOVINE SERUM ALBUMIN; HU PROTEIN; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; NEUTRALIZING ANTIBODY; PROTEIN S 100;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DIABETES MELLITUS; DUODENUM; GENE EXPRESSION; GLYCATION; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INTESTINE INNERVATION; INTESTINE MUSCLE; MALE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; REACTION ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS; DUODENUM; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH; MYENTERIC PLEXUS; NEURONS; NITRIC OXIDE SYNTHASE TYPE I; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33645812741     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2006.00774.x     Document Type: Article

References (43)

1. Camilleri M Advances in diabetic gastroparesis Rev Gastroenterol Disord 2002 2 47 56
2. Shah V Lyford G Gores G Farrugia G Nitric oxide in gastrointestinal health and disease Gastroenterology 2004 126 903 13
3. Takahashi T Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract J Gastroenterol 2003 38 421 30
4. Roufail E Soulis T Boel E Cooper ME Rees S Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine Diabetologia 1998 41 1419 25
5. Stern D Yan SD Yan SF Schmidt AM Receptor for advanced glycation end-products: a multiligand receptor magnifying cell stress in diverse pathologic settings Adv Drug Deliv Rev 2002 54 1615 25
6. Hudson BI Bucciarelli LG Wendt T et al. Blockade of receptor for advanced glycation end-products: a new target for therapeutic intervention in diabetic complications and inflammatory disorders Arch Biochem Biophys 2003 419 80 8
7. Schmidt AM Yan SD Yan SF Stern DM The biology of the receptor for advanced glycation end-products and its ligands Biochem Biophys Acta 2000 1498 99 111
8. Schmidt AM Stern DM RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes Trends Endocrinol Metab 2000 11 368 75
9. Schmidt AM Hofmann M Taguchi A Yan SD Stern DM RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation Semin Thromb Hemost 2000 26 485 93
10. Jakus V Rietbrock N Advanced glycation end-products and the progress of diabetic vascular complications Physiol Res 2004 53 131 42
11. Yan SF Ramasamy R Naka Y Schmidt AM Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond Circ Res 2003 93 1159 69
12. Wendt T Tanji N Guo J et al. Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy J Am Soc Nephrol 2003 14 1383 95
13. Vanderwinden JM Mailleux P Schiffmann SN Vanderhaeghen JJ De Laet MH Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis N Engl J Med 1992 327 511 5
14. Huang PL Dawson TM Bredt DS Snyder SH Fishman MC Targeted disruption of the neuronal nitric oxide synthase gene Cell 1993 75 1273 86
15. Adeghate E al-Ramadi B Saleh AM et al. Increase in neuronal nitric oxide synthase content of the gastroduodenal tract of diabetic rats Cell Mol Life Sci 2003 60 1172 9
16. Wrzos HF Cruz A Polavarapu R Shearer D Ouyang A Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats Dig Dis Sci 1997 42 2106 10
17. Takahashi T Nakamura K Itoh H Sima AA Owyang C Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats Gastroenterology 1997 113 1535 44
18. Spangeus A Suhr O El-Salhy M Diabetic state affects the innervation of gut in an animal model of human type 1 diabetes Histol Histopathol 2000 15 739 44
19. Spangeus A El-Salhy M Myenteric plexus of obese diabetic mice (an animal model of human type 2 diabetes) Histol Histopathol 2001 16 159 65
20. Watkins CC Sawa A Jaffrey S et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy J Clin Invest 2000 106 373 84
21. Nakamura K Takahashi T Taniuchi M Hsu CX Owyang C Nicotinic receptor mediates nitric oxide synthase expression in the rat gastric myenteric plexus J Clin Invest 1998 101 1479 89
22. Nakao K Takahashi T Utsunomiya J Owyang C Extrinsic neural control of nitric oxide synthase expression in the myenteric plexus of rat jejunum J Physiol 1998 507 Pt 2 549 60
23. Sheetz MJ King GL Molecular understanding of hyperglycemia's adverse effects for diabetic complications JAMA 2002 288 2579 88
24. Singh R Barden A Mori T Beilin L Advanced glycation end-products: a review Diabetologia 2001 44 129 46
25. Karachalias N Babaei-Jadidi R Ahmed N Thornalley PJ Accumulation of fructosyl-lysine and advanced glycation end-products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats Biochem Soc Trans 2003 31 1423 5
26. Siemionow M Demir Y Diabetic neuropathy: pathogenesis and treatment J Reconstr Microsurg 2004 20 241 52
27. Thornalley PJ Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options Int Rev Neurobiol 2002 50 37 57
28. Wautier JL Guillausseau PJ Advanced glycation end-products, their receptors and diabetic angiopathy Diabetes Metab 2001 27 535 42
29. Kalousova M Zima T Tesar V Stipek S Sulkova S Advanced glycation end-products in clinical nephrology Kidney Blood Press Res 2004 27 18 28
30. Stern DM Yan SD Yan SF Schmidt AM Receptor for advanced glycation end-products (RAGE) and the complications of diabetes Ageing Res Rev 2002 1 1 15
31. Ishihara K Tsutsumi K Kawane S Nakajima M Kasaoka T The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site FEBS Lett 2003 550 107 13
32. Lander HM Tauras JM Ogiste JS Hori O Moss RA Schmidt AM Activation of the receptor for advanced glycation end-products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress J Biol Chem 1997 272 17810 4
33. Mamputu JC Renier G Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end-products: inhibitory effect of gliclazide Diabetes Obes Metab 2004 6 95 103
34. Thornalley PJ Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs Cell Mol Biol (Noisy-le-grand) 1998 44 1013 23
35. Munch G Gasic-Milenkovic J Arendt T Effect of advanced glycation end-products on cell cycle and their relevance for Alzheimer's disease J Neural Transm Suppl 2003 65 63 71
36. Sorci G Riuzzi F Agneletti AL Marchetti C Donato R S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner J Cell Physiol 2004 199 274 83
37. Usta MF Bivalacqua TJ Yang DY et al. The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats J Urol 2003 170 1437 42
38. Xu B Chibber R Ruggiero D et al. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end-products FASEB J 2003 17 1289 91
39. Matsunaga N Anan I Forsgren S et al. Advanced glycation end-products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation Acta Neuropathol (Berl) 2002 104 441 7
40. Cellek S Qu W Schmidt AM Moncada S Synergistic action of advanced glycation end-products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes Diabetologia 2004 47 331 9
41. Cellek S Foxwell NA Moncada S Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats Diabetes 2003 52 2353 62
42. Uhlmann S Rezzoug K Friedrichs U Hoffmann S Wiedemann P Advanced glycation end-products quench nitric oxide in vitro Graefes Arch Clin Exp Ophthalmol 2002 240 860 6
43. Asahi K Ichimori K Nakazawa H et al. Nitric oxide inhibits the formation of advanced glycation end-products Kidney Int 2000 58 1780 7